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ReviewGlossary
Actomyosin: actin and myosin fibres present in the cytoskeleton.
Emerin: a protein of the inner nuclear envelope.
Integrins: transmembrane proteins that convey forces inside and out of the cell
and activate downstream signalling pathways mediated by the establishment
of large integrin-scaffold protein assemblies called focal adhesions.
iPS cells: induced pluripotent stem cells obtained from adult cells, through
genetic reprograming.
Magnetic actuation: technique of activating mechanotransduction signalling
pathways in cells through the application of magnetic force. The established field
can be static being the force constant, or oscillating showing a pulsed behaviour.
Activation of mechanotransduction signalling pathways can occur within minutes.
Magnetic bioreactor: magnetic array capable of delivering an oscillating
magnetic field to cells growing in standard tissue culture surfaces or
biomaterials. Although the frequency is tunable, values often range between
1 and 3 Hz, which are the closest to physiological stress.
Mechanical cues: physical stimulus present in the cell microenvironment.
PEMF therapy: delivery of pulsed magnetic force for healing purposes, for
example, to bridge a non- or delayed bone fracture.
Reverse piezoelectric effect: mechanical deformation caused by an electrical field.
Rho-GTPases: small signalling G proteins implicated in numerous cells
processes such as cytoskeleton dynamics.
Scaffold: structures from natural of synthetic origin that provides cells physical
support and guidance.
SPIONs: iron oxide nanoparticles with supermagnetic properties used in stem
cell guidance and magnetic resonance.Mechanical stimulus is of upmost importance in tissues
developmental and regeneration processes as well as in
maintaining body homeostasis. Classical physiological
reactions encompass an increase of blood vessel diame-
ter upon exposure to high blood pressure, or the expan-
sion of cortical bone after continuous high-impact
exercise. At a cellular level, it is well established that
extracellular stiffness, topography, and remote magnet-
ic actuation are instructive mechanical signals for stem
cell differentiation. Based on this, biomaterials and their
properties can be designed to act as true stem cell
regulators, eventually leading to important advances
in conventional tissue engineering techniques. This re-
view identifies the latest advances and tremendous
potential of magnetic actuation within the scope of
regenerative medicine and tissue engineering.
Mechanotransduction, magnetic actuation and tissue
engineering – connecting the dots
Mechanical forces exert epigenetic control in tissue devel-
opmental, remodelling, and regeneration processes [1,2].
The first medical evidence of the role of mechanical forces
in tissue remodelling was provided by the German surgeon
Jullius Wolff >100 years ago after detailing the influence of
mechanical load on bone mass and geometry in his study
‘The Law of Bone Transformation’ [3]. Striking evidence of
the impact of mechanical loading on bone remodelling
came from astronauts living under microgravity condi-
tions. Lack of mechanical load led to detrimental effects
such as a significant loss of bone mass, higher incidence of
cardiovascular disease, and signs of accelerated biological
ageing [4]. Increased mechanical load can, in contrast,
have positive effects, as is the case for high-performance
athletes such as Olympic fencers. These athletes under-
take intermittent high-impact activity, leading to expan-
sion of cortical bone, as well as increase of trabecular bone
density and muscle mass [5]. Such strengthening is vital
for the protection of the body from injuries [6].0167-7799/
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magnetic biomaterials.Physiological changes in response to mechanical load
are initiated by a process called mechanotransduction, in
which cells detect mechanical changes in their microenvi-
ronment through specialised machinery and then trans-
late the information into an appropriate biological
response. Mechanotransduction is mediated by structural
proteins such as integrins and actomyosin fibres, which
establish a physical connection between the cell and the
microenvironment. When a mechanical stimulus is applied
to the cell, the increase in tension is transmitted through
the contraction of actomyosin fibres, a process mediated by
the small GTPase Rho and Rho-associated protein kinase
(ROCK) proteins [7].
Mechanotransduction is pivotal in tissue homeostasis;
however, ageing and disease may impair this physiological
process, giving rise to musculoskeletal disorders [8–14], in
particular, the loss of muscle mass and function, decreasedStem cell: undifferentiated cell with the potential of generating several
specialised cell lineages.
Stretch-activated ion channels: ion channels gated in response to alterations of
the conformation of the cytoplasm membrane.
Tissue graft: tissue portion from autologous, allogeneic or xenogeneic source,
employed to repair damaged tissue.
Tissue engineering: use of a combination of materials, cells, active molecules
and engineering principles to restore the biological function of a damaged
tissue or organ.
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that osteoporosis is aggravated in menopause, during
which oestrogen levels are reduced, may in part be
explained by the role of oestrogen as a mechanosensitiser
hormone [8]. Sustaining physiological mechanotransduc-
tion is thus crucial for maintaining tissue homeostasis and
preventing musculoskeletal disorders.
An effective strategy for improving or sustaining mechan-
otransduction is magnetic actuation (see Glossary), which
has been available for nearly three decades in the form of
FDA-approved pulsed electromagnetic field (PEMF) therapy
[18]. Owing to recent progress in nanomedicine and molecu-
lar biology, we can begin to understand the signalling path-
ways involved in mechanotransduction and exploit them
with magnetic actuation for a myriad of applications: stem
cell differentiation and homing to injury sites, as well asBox 1. Overview of proteins involved in mechanotransduction
Focal adhesion (FA) signalling, actomyosin contraction, stretch-
activated ion channels, and nuclear associated proteins [26] are all
important for mechanotransduction (Figure I). Of pivotal importance
are integrins, transmembrane heterodimers proteins composed of a
and b subunits that physically couple the ECM to the cytoskeleton by
linker proteins such as talin and vinculin [27]. The cytoskeleton, com-
posed of actin and myosin fibres, physically bridges the ECM or the cell
membrane to the nucleus. Although the nucleus is the largest and
stiffest organelle in the cell, it is still susceptible to mechanical forces
conveyed through the cytoskeleton [28]. In the nucleus, lamins, tran-
scription regulators Yes-associated protein and tafazzin (YAP/TAZ),
myocardin-related transcription factor A (MRTF-A) and nuclear factor
(NF)-kB all participate in gene regulation triggered by mechanical cues
[29,30].
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Figure I. Overview of mechanotra
2tissue engineering strategies [19–25]. In tissue engineering,
magnetic actuation can allow for better seeding in 3D scaf-
folds [26–28], and can be used in scaffold-free approaches
to build tissues bottom-up from mesenchymal stem cells
(MSCs) or induced pluripotent stem cells (iPSCs) [29–31].
We discuss the fundamentals of mechanotransduction,
the potential use of magnetic actuation in stem cell differ-
entiation and in several aspects of tissue engineering,
focusing on the musculoskeletal system, given its vulnera-
bility to physical strain, and because musculoskeletal dis-
orders are predicted to rise due to an increase of the
ageing population and extension of life expectancy [32,33].
Understanding mechanotransduction and identifying the
potential uses of magnetic actuation will open new and
vibrant avenues for musculoskeletal tissue engineering
and regenerative medicine strategies.Integrins convey forces between inside and outside the cell and
activate downstream signalling pathways. This mechanotransduction
is made possible by the establishment of large integrin–scaffold pro-
tein assemblies called FAs. Besides integrins, cells can perceive ex-
ternal mechanical stimuli through many other proteins such as
cadherins, catenins, the components of the cytoskeleton and nucleos-
keleton, stretch-activated ion-channels, and growth factor receptors.
Similar to integrins, cadherins are transmembrane proteins and im-
portant signalling hubs, but instead of linking the ECM to the cell, they
mediate cell–cell communication. In classical cadherins, the cytoplas-
mic motif is linked to b-catenin. However, because b-catenin is also
implicated in transcriptional processes, it may be translocated from
cadherins to the nucleus in response to intracellular tension, mediated
by signalling components such as the small GTPase Rho and ROCK.
Free molecules
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The study of mechanotransduction is a growing area of
investigation and has revealed a variety of mechanosen-
sors and signalling models (Box 1).
Extracellular stiffness is probably the best-studied me-
chanical property that has been investigated in the context
of stem cell differentiation [34–36] (Table 1). Stem cells
interpret changes in stiffness as alterations in the adhesive
ligand presentation and this interpretation has a regula-
tory role in stem cell fate [37]. However, recent findings
show that mechanotransduction is not restricted to cell
surface receptors and adhesion, but can occur directly
through the nucleus via phosphorylation of emerin [38].
In addition to stiffness, stem cell differentiation can be
regulated by topographical cues [39–42]. Integrins also play
a critical role in this process by mediating cell adhesion
to micro- or nanoscale topographic features, resulting in
the contraction of the cytoskeleton and activation of bio-
chemical signalling pathways [43]. In addition to stiffness
and topography, other important physical cues such as
mechanical loading and shear stress can modulate mechan-
otransduction. Both mechanical loading and shear stress
are important for maintenance of cell phenotype, as well as
for directing stem cell fate towards a specific lineage [44].
Cell tension triggers important biochemical signalling
cascades such as the Rho/ROCK and the mitogen-activated
protein kinase (MAPK) pathways. The Rho/ROCK path-
way has pleiotropic functions, comprising the regulation of
cellular contraction, motility, morphology, polarity, and
cell division, which are considered fundamental in stem
cell specification [7,45]. The extracellular signal-regulated
kinase (ERK) and p38 branches of the MAPK pathway are
also activated upon mechanical stress and are critical
regulators of stem cell fate [46–48]. Interestingly, sus-
tained activation of this pathway is responsible for the
regrowth of limbs in regenerative competent vertebrates
such as salamander [49].
Harnessing cell behaviour at distance
The incorporation of mechanical cues such as stiffness and/
or topography into biomaterials design is certainly drivingTable 1. Effect of mechanical cues in stem cell fate
Mechanical
stimulus
Cell fate
Stiffness Stem cells exposed to substratum of 40 kPa,
matching bone stiffness, undergo specification
towards the osteogenic lineage, whereas when
exposed to 10 kPa, matching muscle rigidity, cells
commit towards the myogenic lineage.
Stem cells cultured in matrices of 40 kPa display
greater abundance of tenogenic markers than
when exposed to 20 or 80 kPa
Topography Porous scaffolds are favourable to osteogenesis,
while aligned fibres provide an instructive niche
for the differentiation of tendon stem/progenitor
cells into tendon-like cells.
Nanopillars and nanoholes enhance
chondrogenesis and facilitates hyaline cartilage
formation
Shear stress,
tension, and
compression
Shear stress modulates the endothelial cell
phenotype, whereas compression forces
promotes the osteogenesisthe fields of regenerative medicine and tissue engineering
forward. Nonetheless, the high cell throughput necessary
to successfully implement clinical therapies is still challeng-
ing [50]. Previous methods relied on biomaterials being in
direct contact with cells, but methods that utilise forces
applied at a distance, such as the reverse piezoelectric effect
and magnetic actuation would be a viable alternative to
increase cell throughput [50]. Mechanotransduction proto-
cols based on the reverse piezoelectric effect entail the
delivery of nanosinusoidal vibrations (termed ‘nanokicking’)
to stem cells. Conveyance of this force to cells can modulate
cell adhesion and phenotype by activating mechanotrans-
duction pathways to drive stem cell specification towards
osteoblastogenesis [50]. Nanokicking may disrupt focal
adhesions and interfere with signalling through G-proteins,
or focal adhesion kinase (FAK) and ERK, which are impli-
cated in the activation of the osteogenic transcription factor
runt-related transcription factor (RUNX)2 [50]. Although
the reverse piezoelectric effect enables high cell throughput,
it is not as versatile as magnetic actuation, nor does it
possess the capacity to activate specific mechanotransduc-
tion pathways.
Magnetic actuation using magnetic force alone is
thought to deform the plasma membrane, thus causing
changes in actomyosin tension levels and promoting cyto-
skeleton reorganisation. Magnetically induced cytoskele-
tal rearrangements can activate different mechanosensors
embedded in the plasma membrane, such as stretch-acti-
vated ion channels and integrins [51], as well as signalling
pathways such as the p38/MAPK pathway (Figure 1A)
[52]. Such changes can also improve cell survival and
viability, decrease the amount of apoptotic molecules
(e.g., caspases), increase the amount of antiapoptotic mole-
cules (e.g., bcl-2), diminish the expression of pluripotent
genes [53], or accelerate osteoblast differentiation, bone
regeneration, and mineralisation [52,54]. Although these
cellular events are mediated by the Rho/ROCK and MAPK
mechanotransduction signalling pathways, other path-
ways such as the AKT/PI3K pathway, which is linked to
the regulation of the cell cycle and directly related to cell
proliferation, can play an important role.
Selectivity of magnetic-based approaches
Utilising magnetic force with the addition of magnetic
particles can allow for additional levels of control over
specific mechanosensors and signalling pathways, and
therefore, cell fate. Under these circumstances, magnetic
actuation has two main components: the magnetic field
and the responsive magnetic nanoparticle [55]. The mag-
netic field can be generated by permanent magnets or
magnetic bioreactors that produce an oscillating pulse [55].
Remote magnetic actuation can be targeted and precise
in comparison to techniques requiring direct contact. For
example, exposing cells to a substrate with a certain physio-
logical rigidity will deform the entire cell or portions of it
indiscriminately, and has little to no control over specific
mechanosensors and signalling pathways. In contrast, re-
mote magnetic actuation in combination with magnetic
nanoparticles can target individual cells through specific
mechanosensors. Targeting is achieved by the functionali-
sation of a magnetic nanoparticle with ligands that bind to3
(A) N
N
N
S
S
S
N
N
S
S
GEFs
ROCK
MLC
LIMK
Actomyosin
contraclity
Acn nucleaon
and polymerisaon
Magnec beads
Site o
f injur
y
Integrins
Rac
CDC42
PAK1
MKK3 MKK6
TIE2 receptors
Magnec beads
Cell migraon,
survival,
cell-cell interacon
Vasculogenesis/
Angiogenesis
MNK1/2
Acn cytoskeleton
ReorganisaonApoptosis
Cytokine producon
Transcriponal regulaon
HSP27
p38δ p38β p38γ p38α
(B)
(C) (D)
Trans
laon
TRENDS in Biotechnology 
Figure 1. Magnetic actuation in cells and strategies for use in differentiation and regeneration. (A) Magnetic actuation. A magnetic field (dashed lines) directly deforms the
cell membrane (blue and yellow bilayer), activating Rac and CDC42, triggering a cascade of signalling events through the p38/MAPK pathway. This leads to actin
cytoskeleton reorganisation, but also other cell responses such as apoptosis, cytokine production, and transcriptional regulation. (B) Magnetic actuation with beads –
twisting. A magnetic field (dashed lines) torques the magnetic beads attached to integrin receptors, changing their conformation and activating cellular events such as
actomyosin contractility, and actin nucleation and polymerisation. (C) Magnetic actuation with beads – clustering. A magnetic field (dashed lines) promotes oligomerisation
of the magnetic beads and clustering of TIE2 receptors, potentially activating numerous cellular events such as migration, survival, cell–cell interaction, and angiogenesis.
(D) Cells labelled with SPIONs-labelled are steered to the site of injury through magnetic actuation. Abbreviations: BAD, BCL2-associated agonist of cell death; eNOS,
endothelial NO synthase; FKHR, forkhead box O1; GEF, Rho guanine nucleotide exchange factor; HSP, heat shock protein; LIMK, LIM kinase; MAPK, mitogen-activated
protein kinase; MKK, mitogen-activated protein kinase kinases; MLC, myosin light chain; MNK, myosin light chain kinase; PAK, p21-activated kinase; PI3K,
phosphatidylinositol 3-kinase; PRAK, p38-related/activated protein kinase; Rac, ras-related C3 botulinum toxin substrate (rho family, small GTP binding protein); ROCK,
Rho-associated protein kinase; SPION, superparamagnetic iron oxide nanoparticle; STAT, signal transducer and activator of transcription; TIE, tyrosine kinase with
immunoglobulin and epidermal growth factor homology domains.
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will thus change the conformation of the targeted mechan-
osensor, either by magnetic twisting (Figure 1B) or cluster-
ing (Figure 1C), activating it and its associated downstream
biochemical signalling pathways.
Magnetic particles can be functionalised with a myriad
of bioactive agents, such as the integrin recognition motif
arginine–glycine–aspartic acid (RGD) peptide, or antibo-
dies to the potassium channel, subfamily K, member 2
(TREK-1). Magnetic actuation of nanoparticles targeted to
TREK-1 causes the upregulation of typical skeletal devel-
opment markers, in particular the transcription factor
SRY (sex determining region Y)-box 9, core binding factor
a1 (Cbfa1) and osteopontin in vitro, and type I collagen
in vivo, whereas actuation of particles targeted to RGD
receptors enhance type I and II collagen synthesis both
in vitro and in vivo [56].
Functionalised magnetic nanoparticles can be used in
combination with osteogenic medium [57], cyclic magneto-
mechanical stimulation [58], and bone morphogenic protein
(BMP)2 to constitute an integrated strategy to promote
bone mineralisation [59].4The combination of magnetic scaffolds with magnetic
force represents another valuable contribution of magnetic
actuation to the field of regenerative medicine and tissue
engineering. Although less selective than magnetically
actuated nanoparticles, magnetically actuated scaffolds
are valuable for developing proangiogenic scaffolds. The
combination of both an oscillating magnetic field and a
magnetic scaffold can drive organisation of endothelial
cells into vessel-like structures [60]. In cardiac tissue
engineering, brief stimulation of cardiac cells (20 min)
was enough to activate the AKT pathway, known to be
implicated in cell hypertrophy and survival [61].
Magnetic actuation in the regeneration compartment
The regeneration compartment or stem cell compartment
encompasses the injury site where healing takes place.
This is a highly complex microenvironment generally com-
posed of stem cells, blood vessels, secreted factors, among
many others such as inflammatory cells, tissue-specific
cells, and extracellular matrix proteins (ECM) proteins.
Endogenous tissue repair benefits from the interplay
between these components with an adequate mechanical
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stress [62].
Endothelial cells in the regeneration compartment play
a pivotal role in tissue regeneration and organogenesis by
secreting autocrine and paracrine factors that are critical
for healing, and contribute to angiogenesis by becoming the
main components of the new blood vessels [63,64]. Angio-
genesis can be stimulated by manipulating integrins
through magnetic twisting (Figure 1B) or the endothelial
receptor cell TIE Tyrosine Kinase 2 (TIE2) through mag-
netic clustering (Figure 1C) [65,66]. Manipulation through
magnetic twisting is achieved using magnetic beads func-
tionalised with RGD-peptide sequences to bind endothelial
integrins. Application of a magnetic field perpendicular to
the magnetic dipole of the bead twists the bead, thus
twisting the integrin. As a result, endothelin (ET)-1 gene
expression is increased by >100% [66]. Manipulation
through clustering is done using magnetic beads functio-
nalised with TIE2 antibodies to target the receptor [65].
Application of a magnetic field clusters the targeted recep-
tors and activates them, resulting in an increase in the
tube-length of vessel-like structures [65].
Haematopoietic stem cells are important sentinels of
the immune system and undertake this surveillance via
clustering of IgE molecules bound to high-affinity IgE
receptors, also known as FceRI. This clustering activates
an intracellular calcium response by raising the intracel-
lular calcium levels and releasing histamine [67]. Ageing
has deleterious effects on haematopoietic stem cells in the
stem cell compartment, thus leading to a condition called
immunosenescense; a state consisting in the reduction of
the competence of the immune system [67]. Decrease in
immunological competence results from the progressive
deterioration of innate and adaptive immune responses
[68]. Magnetic actuation can be a useful tool to fight
immunosenescence by mimicking the action of IgE activity.
This can be achieved by using superparamagnetic nano-
beads that bind to the receptor and oligomerise, clustering
the FceRI receptor upon the application of a magnetic field
in a similar manner as described for integrins in endothe-
lial cells [69].
An important event in regeneration is stem cell reten-
tion and differentiation. Indeed, stem cells possess the
innate ability to migrate towards the site of injury, driven
by specific biochemical and mechanical cues, and to differ-
entiate in situ to promote tissue or organ regeneration.
Long-term success of certain surgical procedures still
requires adjuvant therapy to enhance cell retention at a
specific site. This can be achieved by labelling stem cells with
superparamagnetic iron oxide nanoparticles (SPIONs) and
applying a magnetic field to further guide their migration to
sites requiring increased cell retention [70,71] (Figure 1D).
Importantly, cell labelling with SPIONs appears not
to affect viability, proliferation, or specification of MSCs
into adipogenic, chondrogenic, or osteogenic lineages under
in vivo conditions [72]. Similar findings were observed in
magnetite-labelled neural stem cells [73].
Magnetic actuation in tissue engineering
Conventional tissue engineering strategies typically uti-
lise a combination of cells and 3D scaffolds to regenerate orrepair a portion of injured tissue. These scaffolds are vital
for providing physical and mechanical support for the cells,
and can also deliver chemical stimuli that boost healing
such as BMP2 or basic fibroblast growth factor (bFGF)
[74,75]. However, the regeneration process is driven not
only by chemical factors, but by mechanical cues, and this
is reflected by a paradigm shift in tissue engineering.
Scaffold materials are now designed with specific mechan-
ical cues such as tissue-matching stiffness or anisotropic
surfaces, resulting in improved repair and regeneration.
Despite recent improvements in scaffold design, tissue
engineering still faces a number of challenges. For exam-
ple, once a material is implanted in the body, it may
undergo significant physical and chemical changes due
to protein adsorption [76] and enzymatic degradation
[77], thus skewing the initially designed properties. Other
limitations could be poor cell seeding and invasion due to
the tortuosity and/or depth of the scaffold, or the implanted
material degrading and releasing byproducts that may
trigger inflammatory responses [78]. Magnetic actuation
could be used to circumvent many of the current limita-
tions of tissue engineering [79], for example, to improve cell
seeding efficacies and invasion into 3D scaffolds, or as part
of a scaffold-free strategy to build portions of transplant-
able tissues, thus bypassing the possible inflammatory
response to a scaffold or its degradation byproducts. Mag-
netically actuated scaffolds enable mechanical stimulation
of cells, but also building cell and drug delivery systems on
demand. The possibility of selectively activating mechan-
otransduction pathways to harness stem cell fate [80,81],
as well as exerting a modulatory effect of the immune
system [64], makes this approach all the more attractive.
Magnetic-assisted tissue engineering (Mag-TE)
Mag-TE involves cell labelling with magnetic particles,
which grants them magnetic properties (Figure 2A). In
the presence of proper culturing conditions and with the
application of magnetic force, it is possible to build scaffold-
free portions of skin, liver, or muscle tissue in a variety of
shapes [82]. As a proof-of-concept, oriented dense muscle
sheets, strings, and rings from mouse myoblasts were
produced by Mag-TE [83]. Here, cells were labelled with
magnetite cationic liposomes and seeded on a low-adhesive
24-well plates with a rotating magnet underneath. Cells
were pulled towards the bottom of the plate by magnetic
attraction and formed a dense, multilayered sheet-like
construct. To produce strings that mimic muscle fibre
bundles, the cells were cultured with a steady immobile
magnet underneath, leading to linear cell aggregation,
giving rise to a string-like 3D tissue construct.
One of the challenges in the construction and mainte-
nance of myoblast sheets and strings is that these struc-
tures shrink considerably over longer cell culture periods,
and thus must be stretched, aligned, and anchored to
retain their shape and properties. A myoblast cell ring
can be used to achieve this function [83]. To create such
rings, a suspension of myoblast cells is seeded in a low
adhesive cell culture plate with a polycarbonate cylinder
placed in the centre. Once the cylinder is fixed, a magnet is
placed underneath to accumulate the cells on the bottom of
the plate. After a few days in culture, the cell layer shrinks5
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Figure 2. Magnetic actuation strategies for tissue engineering. (A) Production of a cell sheet with magnetically prelabelled cells. Cell expansion of magnetically labelled
cells in a low-adhesive cell culture Petri dish placed on top of a magnet yields an easily detachable cell sheet. (B) Cell seeding and invasion in a 3D porous scaffold with
magnetically prelabelled cells. Placing a magnet underneath the tissue-engineered construct promotes cell migration into the porous scaffold and homogeneous
dispersion. (C) Magnetically actuated scaffolds. The application of a magnetic field will potentially induce a structural deformation in the scaffold and cells. (D) Ferrogels
releasing cells and biomolecules on demand through the establishment of an alternating magnetic field.
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cell sheets and strings. In addition to such proof-of-concept
studies, Mag-TE has also been assessed in vivo in a bone
regeneration model [29]. In this model, human multilay-
ered MSC sheets were produced and implanted in the
cranial defect of a nude rat with histological findings
showing significant bone growth 14 days post-implanta-
tion. This technique has been also used in proangiogenic
therapy, where multilayered adipose-derived stem cell
sheets and iPSC sheets were generated and engrafted
successfully in ischaemic mouse models to promote vascu-
larisation of the hypoxic tissue [30,31].
Magnetic-assisted cell seeding (Mag-seeding)
One of the classical techniques in tissue engineering
involves cell seeding into a porous 3D scaffold, followed
by proliferation and differentiation. After acquisition of
tissue-like characteristics, where cells are organised in a
way resembling the native tissue and displaying markers
of it (e.g., osteocalcin and alkaline phosphatase are typical
of bone tissue), the construct is implanted at the injury site.
Cell seeding and invasion can still be challenging due to
the depth and/or tortuosity of 3D scaffolds.
Mag-seeding can overcome this limitation. In this tech-
nique, cells are labelled with magnetic particles, placed on
top of the scaffold, and then driven to invade the scaffold by
magnetic forces from below (Figure 2B). Mag-seeding has
proven effective in promoting infiltration and distribution6of magnetically labelled fibroblasts in poly(lactic-co-
glycolic acid) (PLGA), collagen, and polystyrene materials
[26–28]. This strategy can be used with great precision,
enabling distribution of cells with a high degree of spatial
resolution. In this respect, magnetic tweezers are success-
fully used to probe and position labelled cells, allowing the
seeding cells at high densities, as well as finely-tuned
spatial organisation inside the construct [84].
Magnetic biomaterials
Soft and hard materials are susceptible to acquiring mag-
netic properties through the incorporation of magnetic iron
oxide particles, as demonstrated in the development of
magnetic hydrogels [85], magnetic bioactive glasses [86]
magnetic blends of poly(caprolactone) (PCL)/hydroxyapa-
tite [86], magnetic nanofibrous hydroxyapatite poly-lactide
acid (PLA) [87],and magnetic PCL [88]. The methods for
incorporation of magnetic particles in biomaterials include
doping, blending, in situ precipitation, and the ‘grafting-
onto’ method [89]. For the purposes of tissue engineering, a
material is considered to have satisfactory magnetic prop-
erties if magnetic saturation values are above 0.049 emu/g
[90].
Magnetic biomaterials in combination with magnetic
force provide numerous benefits unavailable to other
methods and materials [55]. This approach permits the
construction of magnetically actuated scaffolds with angio-
genic [60] and osteogenic [88] potential, both of which are
Box 2. Outstanding questions
 Given the complexity of the translational process from the bench to
the bedside, how long will we have to wait to benefit from patient
tailored mechanotherapies?
 Can we build standardised stem cell differentiation protocols
based on magnetic actuation?
 What is the overall impact of magnetic actuation within the re-
generation compartment?
 Functional multilayered iPSCs sheets were constructed for angio-
genic therapy: what other development can we expect?
 Can selective mechanotransduction strategies based on magnetic
twisting and clustering help implementing and expanding the use of
MSCs and iPSCs in tissue engineering and regenerative medicine?
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and biochemical mechanisms underlying this response
remain elusive, it is postulated that magnetisation induces
local deformation of the scaffold, which in turns mechani-
cally stimulates cells [61] (Figure 2C).
Magnetically actuated scaffolds also provide a platform
for cell and drug delivery on demand [85]. Typically, this is
performed with ferromagnetic hydrogels (ferrogels), con-
sisting of hydrogels incorporating ferromagnetic particles
and further enriched with growth factors and/or cells
(Figure 2D). Upon the application of a magnetic field,
the hydrogel contracts, expelling the biomolecules and/or
cells contained within it (Figure 2D) [85]. If the ferrogel is
placed at an injury site, it can act as a potent delivery
vehicle. Alternatively to release on-demand, growth factors
can be covalently conjugated to the ferromagnetic particles
to be delivered in a sustained manner [91]. For example,
bFGF-conjugated particles embedded in fibrin hydrogels
were found to encourage the proliferation and differentia-
tion of cells to be used in the regeneration of spinal cord
injuries, as compared to hydrogels containing free bFGF
[91].
Magnetic materials are often obtained through the
incorporation with iron oxide nanoparticles and although
iron is an essential mineral of our body, the size of such
particles raises a number of safety concerns with respect to
their use in medicine, such as cytotoxicity, bioaccumula-
tion, and inflammation [92]. However, such concerns have
been dissipated by a number of in vivo tests demonstrating
that magnetic nanofibrous scaffolds of PCL implanted
subcutaneously [93] and magnetic hydroxyapatite/collagen
scaffolds implanted in rabbit distal femoral epiphysis and
tibial mid-diaphysis did not appear to cause inflammation
[94]. Furthermore, magnetic hydroxyapatite, prepared
with different ratios of magnetic particles, when implanted
in rabbit bone critical size defects produced in the condyle
region, had similar biocompatibility to hydroxyapatite
alone [95]. Indeed, it has been observed that granting
magnetic properties to biomaterials can lead to a signifi-
cant increase in cell proliferation [95,96]. The mechanisms
underlying this stimulation still need to be elucidated.
These results, as well as the fact that uptake of SPIONs
has no impact on viability or differentiation potential in a
diverse array of cells [72,73], are good indicators of the
safety of magnetically actuated materials. However, long-
term in vivo tests must be undertaken before drawing
further conclusions.
Concluding remarks and future perspectives
Magnetic actuation, especially in combination with mag-
netic nanoparticles, is a valuable tool for harnessing stem
cell guidance, retention, and differentiation. This technol-
ogy is also promising in promoting the occurrence of key
cellular events within the regeneration compartment, such
as angiogenesis, and in ameliorating competence of the
immune system.
Other important contributions of magnetic actuation
can be found in tissue engineering, where this technology
is being effectively used in building scaffold-free tissue
constructs, enhancing cell seeding efficacies in 3D scaf-
folds, and interestingly in magnetic responsive materials.Indeed, another approach we strongly consider for the
future lies in magnetically actuated scaffolds. These could
be prevascularised and implanted, for example, in a bone
defect and further exposed to a magnetic field to mechani-
cally stimulate cells within the regeneration compartment.
To conclude, we anticipate that magnetically based
approaches will bring remarkable progress to regenerative
medicine and will help improve the treatment efficacy of
musculoskeletal disorders and fight healing constraints
(Box 2).
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